Northern Trust Corp Green Light Biosciences Holdings, Pbc Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.18 - $0.48 $100,214 - $267,239	-556,749 Reduced 77.23%	164,140 $49,000
Q1 2023 May 15, 2023	SELL	$0.34 - $1.19 $15,545 - $54,407	-45,721 Reduced 5.96%	720,889 $309,000
Q4 2022 Feb 13, 2023	BUY	$1.03 - $2.0 $172,242 - $334,452	167,226 Added 27.9%	766,610 $904,000
Q3 2022 Nov 14, 2022	BUY	$0.42 - $3.92 $163,496 - $1.53 Million	389,278 Added 185.28%	599,384 $1.39 Million
Q2 2022 Aug 12, 2022	BUY	N/A	105,625 Added 101.09%	210,106 $465,000

Q1 2022 May 13, 2022	BUY	N/A	104,481 New	104,481 $1.01 Million

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.